Vitamin variants could combat cancer as scientists unravel B12 secrets

October 8, 2012
Vitamin variants could combat cancer as scientists unravel B12 secrets

(Phys.org)—In a development that may lead to new drugs to treat cancer, scientists at the University have discovered the process by which a key vitamin (B12) is made in cells.

A team at the University's School of Biosciences led by Professor Martin Warren devised a method that allows them to study how the individual steps for construction are pieced together. B12 is an essential nutrient that plays an important role in the formation of and the maintenance of the nervous system. Deficiencies are associated with anaemia, cardiovascular disorders and dementia.

Using techniques of the new discipline of synthetic biology, researchers engineered a of molecular machines for the construction of the vitamin within bacteria. By varying the length of the , they were able to unravel how the vitamin is manufactured.

Significantly, the team were also able to alter some of the molecular machines on the conveyor belt and change the form of the vitamin that is made. It is hoped that these novel variant forms of the vitamin will act as important to treat diseases such as cancer and infections such as tuberculosis (TB).

The team's research paper An enzyme-trap approach allows isolation of intermediates in cobalamin (vitamin B12) is published in the current edition of the journal Nature .

Professor Warren, who is Head of the School of Biosciences, said: 'This is a really important step forward. Vitamin B12 is a nutrient that is only made by bacteria and is not present in plants. Therefore a significant proportion of the world's population, including vegetarians, are at risk of B12 deficiency.

'Our work will assist in the generation of better ways of making more of this vitamin available and is also permitting us to make new compounds that will literally allow us to throw a spanner in the works of infections such as TB and diseases such as cancer.'

The Kent team worked with several partners including new biotechnology company Cangenix, based at the School of Biosciences, and researchers at Queen Mary, University of London (QM). The research was funded by a research grant from the Biotechnology and Biological Sciences Research Council to Professor Warren and Professor Richard Pickersgill of QM.

Explore further: Researchers discover gene behind devastating vitamin B12-related disorder

Related Stories

Vitamin B12 may protect the brain in old age

September 8, 2008

Vitamin B12, a nutrient found in meat, fish and milk, may protect against brain volume loss in older people, according to a study published in the September 9, 2008, issue of Neurology, the medical journal of the American ...

Vitamin B12 may reduce risk of Alzheimer's disease

October 18, 2010

A new study shows that vitamin B12 may protect against Alzheimer's disease, adding more evidence to the scientific debate about whether the vitamin is effective in reducing the risk of memory loss. The research will be published ...

Recommended for you

Brazilian wasp venom kills cancer cells by opening them up

September 1, 2015

The social wasp Polybia paulista protects itself against predators by producing venom known to contain a powerful cancer-fighting ingredient. A Biophysical Journal study published September 1 reveals exactly how the venom's ...

Naturally-occurring protein enables slower-melting ice cream

August 31, 2015

(Phys.org)—Scientists have developed a slower-melting ice cream—consider the advantages the next time a hot summer day turns your child's cone with its dream-like mound of orange, vanilla and lemon swirls with chocolate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.